← Back to feedRead original →
VERIFIEDET Finance·neutral
Lupin launches generic Sugammadex injection in US
AI Summary
- ·Lupin Limited has launched its Sugammadex Injection in the United States.
- ·The launch follows approval from the US Food and Drug Administration.
- ·The injection is indicated for reversing neuromuscular blockade in surgical patients.